Comparison between Credila Financial IPO and Gujarat Kidney IPO.
Credila Financial IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Gujarat Kidney IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Credila Financial IPO is up to ₹5,000.00 Cr whereas the issue size of the Gujarat Kidney IPO is up to ₹250.80 Cr. The final issue price of Credila Financial IPO is and of Gujarat Kidney IPO is ₹114.00 per share.
| Credila Financial IPO | Gujarat Kidney IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹108.00 per share | |
| Issue Price (Upper) | ₹114.00 per share | |
| Issue Price (Final) | ₹114.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 128 shares | |
| Fresh Issue Size | 0 shares | 2,20,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹3,000.00 Cr | up to ₹250.80 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹2,000.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 2,20,00,000 shares |
| Issue Size Total (Amount) | up to ₹5,000.00 Cr | up to ₹250.80 Cr |
Credila Financial IPO opens on , while Gujarat Kidney IPO opens on Dec 22, 2025. The closing date of Credila Financial IPO and Gujarat Kidney IPO is , and Dec 24, 2025, respectively.
| Credila Financial IPO | Gujarat Kidney IPO | |
|---|---|---|
| Anchor Bid Date | Dec 19, 2025 | |
| Issue Open | Dec 22, 2025 | |
| Issue Close | Dec 24, 2025 | |
| Basis Of Allotment (Tentative) | Dec 26, 2025 | |
| Initiation of Refunds (Tentative) | Dec 29, 2025 | |
| Credit of Share (Tentative) | Dec 29, 2025 | |
| Listing date (Tentative) | Dec 30, 2025 | |
| Anchor Lockin End date 1 | Jan 24, 2026 | |
| Anchor Lockin End date 2 | Mar 25, 2026 |
Credila Financial IPO P/E ratio is , as compared to Gujarat Kidney IPO P/E ratio of 61.62.
| Credila Financial IPO | Gujarat Kidney IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Credila Financial Services Ltd.'s revenue increased by 70% and profit after tax (PAT) rose by 87% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Gujarat Kidney & Super Speciality Ltd.'s revenue increased by 637% and profit after tax (PAT) rose by 454% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 63.96 | 99.1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 61.62 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹898.81 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 14.41% | 36.61% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 37.65% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 4.47 | 0.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 14.41 | 36.61% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Credila Financial IPO Retail Individual Investors (RII) are offered 0 shares while in Gujarat Kidney IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Credila Financial IPO and 77,26,880 shares in Gujarat Kidney IPO.
| Credila Financial IPO | Gujarat Kidney IPO | |
|---|---|---|
| Anchor Investor Reservation | 87,73,120 shares | |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 77,26,880 shares |
| NII | 0 shares | 33,00,000 shares |
| RII | 0 shares | 22,00,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 2,20,00,000 shares |
Credila Financial IPO subscribed in total, whereas Gujarat Kidney IPO subscribed 5.21x.
| Credila Financial IPO | Gujarat Kidney IPO | |
|---|---|---|
| QIB (times) | 1.06x | |
| NII (times) | 5.73x | |
| Big NII (times) | 5.25x | |
| Small NII (times) | 6.68x | |
| RII (times) | 19.04x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 5.21x |
